Daniel Gamu Selected Research

sarcolipin

1/2019	Phospholamban deficiency does not alter skeletal muscle SERCA pumping efficiency or predispose mice to diet-induced obesity.
5/2017	Sarcolipin expression is not required for the mitochondrial enzymatic response to physical activity or diet.
1/2017	Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice.
1/2016	Sarcolipin knockout mice fed a high-fat diet exhibit altered indices of adipose tissue inflammation and remodeling.
9/2015	Persistence of diet-induced obesity despite access to voluntary activity in mice lacking sarcolipin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Gamu Research Topics

Disease

3	Obesity 01/2019 - 09/2015
2	Glucose Intolerance 01/2019 - 05/2017
2	Atrophy 01/2018 - 01/2017
2	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2017 - 08/2015
2	Muscular Atrophy (Muscle Atrophy) 01/2017 - 01/2016
1	Osteoporosis 01/2018
1	Inflammation (Inflammations) 01/2016
1	AIDS-Related Complex (ARC) 03/2015
1	Weight Gain 09/2013

Drug/Important Bio-Agent (IBA)

5	sarcolipinIBA 01/2019 - 09/2015
3	phospholambanIBA 01/2019 - 08/2015
3	Proteins (Proteins, Gene)FDA Link 05/2017 - 09/2015
2	Adenosine Triphosphatases (ATPase)IBA 05/2017 - 09/2015
1	Biological ProductsIBA 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2016
1	CatecholaminesIBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Apoptosis Inducing FactorIBA 03/2015
1	CalpainIBA 03/2015
1	CaspasesIBA 03/2015
1	Apoptosis Regulatory ProteinsIBA 03/2015
1	CalciumIBA 03/2015
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2013
1	Propranolol (Inderal)FDA LinkGeneric 09/2013